The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes. The study population — 440 adults and children 6 ...
Caution: The iLet ® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The ...
The investigational insulin-only iLet Bionic Pancreas (Beta Bionics) reduced A1c without increasing hypoglycemia in adults and children with type 1 diabetes with greater automation than currently ...
ConvaTec is a leading global manufacturer of widely popular infusion sets offering a variety of patient choice Beta Bionics is developer of the iLet Bionic Pancreas System and is committed to device ...
Abbott Laboratories is back with another collaboration in the diabetes tech space. The Abbott Park, IL-based company announced an agreement with Beta Bionics, the developer of the iLet Bionic Pancreas ...
The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...
Beta Bionics, Inc., a clinical stage medical technology company, announced that the results of the multi-centre randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT) were presented by Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results